Question # 1 (Multiple Answer) Concerning oral administration -- disadvantages
A) least economical
B) drug taken orally may cause emesis
C) drug taken orally may be destroyed by gastric acidity
D) drug taken orally may be metabolized by gastrointestinal flora
E) drug taken orally may be in consistently absorbed due to the presence of food
Question # 2 (Multiple Answer) Typical properties of carrier-mediated drug transport:
A) non-saturable
B) active transport
C) energy requiring
D) inhibitable
Question # 3 (Multiple Choice) Driving force in drug movement in aqueous diffusion model:
A) active transport-- energy requiring
B) facilitated transport
C) drug concentration gradient
Question # 4 (Multiple Choice) Renal excretion factor most likely to be sensitive to drug ionization state:
A) glomerular filtration
B) passive tubular reabsorption
Question # 5 (Multiple Choice) Drug(s) which exhibit(s) a high hepatic" first-pass" effect:
A) lidocaine
B) propranolol
C) both
D) neither
Question # 6 (Multiple Choice) Permanently charged amine form:
A) primary amine
B) secondary amine
C) tertiary amine
D) quaternary amine
Question # 7 (Multiple Answer) For high extraction-ratio drugs, patient to patient bioavailability may vary due to differences in:
A) hepatic function
B) blood flow
C) the presence of hepatic disease
Question # 8 (Multiple Answer) Factors associated with drug absorption that can result in incomplete absorption
A) drug metabolism by gastrointestinal flora
B) drug hydrophilicity (opposite of lipophilicity)
C) drug instability in gastric acid
D) presence of food in the GI tract
E) drug-drug interactions
Question # 9 (Multiple Answer) Drug characteristics contributing to reliable transdermal drug absorption:
A) molecular weight less than 1000
B) drug does not cause histamine release
C) the daily drug requirement is less than 10 mg
D) in saturated aqueous solution, the pH range is 5-9
Question # 10 (Multiple Choice) Concerning parenteral drug administration:
A) less predictable compared to oral administration route
B) not acceptable for unconscious patients
C) rate of drug systemic absorption insensitive to drug solubility in interstitial fluid
D) rate of systemic drug absorption following parenteral administration depends on absorbing capillary membrane surface area
Question # 11 (Multiple Answer) Pharmacokinetic advantages associated with transdermal drug delivery:
A) relatively constant, sustained therapeutic plasma drug concentrations
B) commonly low side-effect incidence
C) good patient compliance
Question # 12 (Multiple Choice) Drugs for which "first-pass" pulmonary uptake may exceed 65% of injected dose:
A) fentanyl
B) alfentanil
C) sufentanil
D) meperidine
E) all of the above
Question # 13 (Multiple Answer) Roots of administration that avoid "first-pass" hepatic effects:
A) sublingual
B) oral
C) transdermal
D) lower rectal suppositories
E) inhalation
Question # 14 (Multiple Choice) Drugs least likely to penetrate across membranes:
A) protein-bound drugs
B) charged drugs
C) neutral drugs
Question # 15 (Multiple Answer) Available for transdermal drug delivery:
A) scopolamine
B) fentanyl
C) nitroglycerin
Question # 16 (Multiple Answer) Concerning "first pass" elimination:
????: Study Temple-All kinds of Study Material MCQs : Pharmacokinetics
A) drug is first transported across the gut wall into the portal circulation
B) drug metabolism may occur in the intestinal wall
C) sometimes extensive drug metabolism may occur in the liver
D) the liver may excrete drug into the bile
E) first-pass effects may reduce drug bioavailability
Question # 17 (Multiple Answer) Factor(s) which effect a drug's volume of distribution:
A) patient's gender
B) patien'ts age
C) presence of disease
D) drug pKa
E) extent of drug-plasma protein binding
Question # 18 (Multiple Choice) Two most important sites for drug elimination:
A) pulmonary and liver
B) liver and gastrointestinal tract
C) kidney and liver
D) skin and liver
E) pulmonary and kidney
Question # 19 (Multiple Choice) Concerning transfer of basic drugs such as nonionized local anesthetics from mother to fetus:
A) fetal pH is higher than maternal pH
B) in fetal distress alkalosis contributes to local anesthetic accumulation
C) concerning maternal blood: fetal blood -- gradient is maintained for continual local anesthetic transfer from maternal circulation to fetal circulation
Question # 20 (Multiple Answer) Characteristics of renal drug excretion:
A) nearly all drugs are filtered at the glomerulus
B) drugs which are weak acids are excreted faster in acidic urinary pH
C) drugs which are weak base is our excreted faster in alkaline urinary pH
D) body fluids where pH differences from blood pH may favor on and trapping include breast milk and aqueous humor (eye)
--------------------------------------------------------------------------
Correct Answers
Now you can see what's hidden
Question # 1 (Multiple Answer) Concerning oral administration -- disadvantages
(B) drug taken orally may cause emesis
(C) drug taken orally may be destroyed by gastric acidity
(D) drug taken orally may be metabolized by gastrointestinal flora
(E) drug taken orally may be in consistently absorbed due to the presence of food
Question # 2 (Multiple Answer) Typical properties of carrier-mediated drug transport:
(B) active transport
(C) energy requiring
(D) inhibitable
Question # 3 (Multiple Choice) Driving force in drug movement in aqueous diffusion model:
Answer: (C) drug concentration gradient
Question # 4 (Multiple Choice) Renal excretion factor I most likely to be sensitive to drug ionization state:
Answer: (B) passive tubular reabsorption
Question # 5 (Multiple Choice) Drug(s) which exhibit(s) a high hepatic" first-pass" effect:
Answer: (C) both
Question # 6 (Multiple Choice) Permanently charged amine form:
Answer: (D) quaternary amine
Question # 7 (Multiple Answer) For high extraction-ratio drugs, patient to patient bioavailability may vary due to differences in:
(A) hepatic function
(B) blood flow
(C) the presence of hepatic disease
Question # 8 (Multiple Answer) Factors associated with drug absorption that can result in incomplete absorption
(A) drug metabolism by gastrointestinal flora
(B) drug hydrophilicity (opposite of lipophilicity)
(C) drug instability in gastric acid
(D) presence of food in the GI tract
(E) drug-drug interactions
Question # 9 (Multiple Answer) Drug characteristics contributing to reliable transdermal drug absorption:
(A) molecular weight less than 1000
(B) drug does not cause histamine release
(C) the daily drug requirement is less than 10 mg
(D) in saturated aqueous solution, the pH range is 5-9
Question # 10 (Multiple Choice) Concerning parenteral drug administration:
????: Study Temple-All kinds of Study Material MCQs : Pharmacokinetics
Answer: (D) rate of systemic drug absorption following parenteral administration depends on absorbing capillary membrane surface area
Question # 11 (Multiple Answer) Pharmacokinetic advantages associated with transdermal drug delivery:
(A) relatively constant, sustained therapeutic plasma drug concentrations
(B) commonly low side-effect incidence
(C) good patient compliance
Question # 12 (Multiple Choice) Drugs for which "first-pass" pulmonary uptake may exceed 65% of injected dose:
Answer: (E) all of the above
Question # 13 (Multiple Answer) Roots of administration that avoid "first-pass" hepatic effects:
(A) sublingual
(C) transdermal
(D) lower rectal suppositories
(E) inhalation
Question # 14 (Multiple Choice) Drugs least likely to penetrate across membranes:
Answer: (A) protein-bound drugs
Question # 15 (Multiple Answer) Available for transdermal drug delivery:
(A) scopolamine
(B) fentanyl
(C) nitroglycerin
Question # 16 (Multiple Answer) Concerning "first pass" elimination:
(A) drug is first transported across the gut wall into the portal circulation
(B) drug metabolism may occur in the intestinal wall
(C) sometimes extensive drug metabolism may occur in the liver
(D) the liver may excrete drug into the bile
(E) first-pass effects may reduce drug bioavailability
Question # 17 (Multiple Answer) Factor(s) which effect a drug's volume of distribution:
(A) patient's gender
(B) patien'ts age
(C) presence of disease
(D) drug pKa
(E) extent of drug-plasma protein binding
Question # 18 (Multiple Choice) Two most important sites for drug elimination:
Answer: (C) kidney and liver
Question # 19 (Multiple Choice) Concerning transfer of basic drugs such as nonionized local anesthetics from mother to fetus:
Answer: (C) concerning maternal blood: fetal blood -- gradient is maintained for continual local anesthetic transfer from maternal circulation to fetal circulation
Question # 20 (Multiple Answer) Characteristics of renal drug excretion:
(A) nearly all drugs are filtered at the glomerulus
(D) body fluids where pH differences from blood pH may favor on and trapping include breast milk and aqueous humor (eye)
MCQS: Pharmcokinetics
????: Study Temple-All kinds of Study Material MCQs : Pharmacokinetics
Question # 1 (Multiple Answer) Factors that could change intrinsic hepatic clearance include:
A) hepatic blood flow
B) induction state of hepatic enzymes
C) hepatic disease
Question # 2 (True/False) In rheumatoid arthritis patients, increased alpha1-acidic glycoprotein may be associated with increased lidocaine protein binding.
A) true
B) false
Question # 3 (Multiple Choice) Hepatic flow-dependent drug elimination refers to:
A) changes in plasma protein concentration
B) rate-limiting step is drug delivery to hepatic elimination sites
????: Study Temple-All kinds of Study Material MCQs : Pharmacokinetics
C) number of functional hepatocytes
D) carrier saturation
E) drug transfer rates across hepatic cell membrane
Question # 4 (Multiple Answer) Characteristic(s) of a drug whose action is terminate by redistribution include:
A) generally long-acting
B) usually a hydrophilic (not very lipid-soluble) drug
C) eventually concentrates usually in adipose (fat) tissue
D) tends to partition slowly into organs such as the brain, even though the brain receives a significant fraction of the cardiac output
Question # 5 (Multiple Choice) Cytochrome P450 induction (increased, amount of P450 enzyme protein) is often associated with:
A) increased enzyme synthesis rates
B) reduced enzyme degradation rates
C) both
D) neither
Question # 6 (Multiple Choice) Microsomal drug metabolizing enzymes are typically associated with:
A) rough endoplasmic reticulum
B) smooth endoplasmic reticulum
Question # 7 (Multiple Answer) Characteristics of drug-protein binding:
A) often parallels drug lipid solubility
B) drug-plasma albumin binding tends to be relatively nonselective
C) real failure he is associated with the reduction in drug-down fraction because of a reduction in plasma albumin concentration
D) in rheumatoid arthritis patients, increased alpha1-acidic glycoprotein tends to promote increased lidocaine protein binding
E) Surgery may result in increases in alpha1-acidic glycoprotein plasma concentration
Question # 8 (Multiple Choice) Examples of "high-extraction" drugs -- related to hepatic drug clearance:
A) morphine
B) meperidine
C) verapamil
D) diltiazem
E) all the above
Question # 9 (Multiple Choice) Pharmacogenetic effects:
A) prolonged mivacurium-induced neuromuscular blockade due to atypical cholinesterase
B) succinylcholine or volatile anesthetic-induced malignant hyperthermia
C) both
D) neither
Question # 10 (Multiple Answer) Characteristics of drug conjugates (following conjugation reactions)
A) more polar
B) more readily excreted
C) typically more pharmacologically active
Question # 11 (Multiple Choice) Termination of pharmacological action of thiopental occurs mainly by:
A) metabolism
B) excretion
C) redistribution
Question # 12 (Multiple Answer) Concerning influence of age on drug responses:variation in response usually due to:
A) reduced cardiac output
B) reduced hepatic perfusion
C) decreased body fat
D) increased protein binding
E) decreased renal function
Question # 13 (Multiple Choice) Reaction type associated with inactivation of succinylcholine, atracurium, and mivacurium.
A) conjugation
B) hydrolysis
C) oxidation
D) reduction
Question # 14 (Multiple Answer) Phase II and reactions:
A) conjugation
B) hydrolysis
C) oxidation
D) reduction
Question # 15 (Multiple Choice) Factors affecting renal clearance of drugs:
A) the presence of renal disease
B) drug secretion rates
C) number of functional nephrons
D) blood flow
E) all of the above
Question # 16 (Multiple Choice) Concerning drug-plasma protein binding:
A) Drugs are seldom bound to plasma proteins
B) volume of distribution is not influenced by protein binding
C) diazepam is an example of the drug that is minimally protein-bound
D) drug clearance is influenced by the extent of protein binding
Question # 17 (Multiple Choice) Mixed function oxidases system is referred to as mediating:
A) phase I system
B) phase II system
Question # 18 (Multiple Answer) Characteristics of drug-protein binding
A) generally theextent of drug-protein binding parallels drug lipids liability
B) drug-plasma albumin binding is usually highly selective
C) renal failure may decrease drug bound fraction because of reduced plasma albumin
D) sulfonamides may displace unconjugated bilirubin from albumin-binding sites (because neonatal bilirubin encephalopathy)
Question # 19 (Multiple Answer) Factors affecting hepatic drug clearance:
A) drug delivery to liver elimination sites
B) extent of plasma protein-bound drug
C) blood flow
D) carrier saturation
E) Wally and filtered in the glomerulus
Question # 20 (Multiple Choice) Factors affecting renal drug secretion rates:
A) carrier saturation
B) drug transfer rates across tubular membranes
C) degree of drug-plasma protein binding
D) rate of drug delivery to secretory sites
E) all the above
Question # 21 (Multiple Choice) Concerning drug-plasma protein binding:
A) A relatively small percentage of drugs are bound to some extent to plasma proteins
B) drug-plasma albumin binding is often highly selective
C) an example of a plasma protein important for drug binding is alpha1-acidic glycoprotein
D) volume of distribution is generally unrelated to protein binding
E) diazepam is an example of a drug that exhibits little plasma protein binding
--------------------------------------------------------------------------
Correct Answers
Now you can see what's hidden
Question # 1 (Multiple Answer) Factors that could change intrinsic hepatic clearance include:
(A) hepatic blood flow
(B) induction state of hepatic enzymes
(C) hepatic disease
Question # 2 (True/False) In rheumatoid arthritis patients, increased alpha1-acidic glycoprotein may be associated with increased lidocaine protein binding.
Answer: True
Question # 3 (Multiple Choice) Hepatic flow-dependent drug elimination refers to:
Answer: (B) rate-limiting step is drug delivery to hepatic elimination sites
Question # 4 (Multiple Answer) Characteristic(s) of a drug whose action is terminate by redistribution include:
(C) eventually concentrates usually in adipose (fat) tissue
Question # 5 (Multiple Choice) Cytochrome P450 induction (increased, amount of P450 enzyme protein) is often associated with:
Answer: (C) both
Question # 6 (Multiple Choice) Microsomal drug metabolizing enzymes are typically associated with:
Answer: (B) smooth endoplasmic reticulum
Question # 7 (Multiple Answer) Characteristics of drug-protein binding:
(A) often parallels drug lipid solubility
(B) drug-plasma albumin binding tends to be relatively nonselective
(D) in rheumatoid arthritis patients, increased alpha1-acidic glycoprotein tends to promote increased lidocaine protein binding
Question # 8 (Multiple Choice) Examples of "high-extraction" drugs -- related to hepatic drug clearance:
Answer: (E) all the above
Question # 9 (Multiple Choice) Pharmacogenetic effects:
Answer: (C) both
Question # 10 (Multiple Answer) Characteristics of drug conjugates (following conjugation reactions)
(A) more polar
(B) more readily excreted
Question # 11 (Multiple Choice) Termination of pharmacological action of thiopental occurs mainly by:
Answer: (C) redistribution
Question # 12 (Multiple Answer) Concerning influence of age on drug responses:variation in response usually due to:
(A) reduced cardiac output
(B) reduced hepatic perfusion
(E) decreased renal function
Question # 13 (Multiple Choice) Reaction type associated with inactivation of succinylcholine, atracurium, and mivacurium.
Answer: (B) hydrolysis
Question # 14 (Multiple Answer) Phase II and reactions:
(A) conjugation
(B) hydrolysis
(C) oxidation
(D) reduction
Question # 15 (Multiple Choice) Factors affecting renal clearance of drugs:
Answer: (E) all of the above
Question # 16 (Multiple Choice) Concerning drug-plasma protein binding:
Answer: (D) drug clearance is influenced by the extent of protein binding
Question # 17 (Multiple Choice) Mixed function oxidases system is referred to as mediating:
Answer: (A) phase I system
Question # 18 (Multiple Answer) Characteristics of drug-protein binding
(A) generally theextent of drug-protein binding parallels drug lipids liability
(D) sulfonamides may displace unconjugated bilirubin from albumin-binding sites (because neonatal bilirubin encephalopathy)
Question # 19 (Multiple Answer) Factors affecting hepatic drug clearance:
(A) drug delivery to liver elimination sites
(B) extent of plasma protein-bound drug
(C) blood flow
Question # 20 (Multiple Choice) Factors affecting renal drug secretion rates:
Answer: (E) all the above
Question # 21 (Multiple Choice) Concerning drug-plasma protein binding:
Answer: (C) an example of a plasma protein important for drug binding is alpha1-acidic glycoprotein
A) least economical
B) drug taken orally may cause emesis
C) drug taken orally may be destroyed by gastric acidity
D) drug taken orally may be metabolized by gastrointestinal flora
E) drug taken orally may be in consistently absorbed due to the presence of food
Question # 2 (Multiple Answer) Typical properties of carrier-mediated drug transport:
A) non-saturable
B) active transport
C) energy requiring
D) inhibitable
Question # 3 (Multiple Choice) Driving force in drug movement in aqueous diffusion model:
A) active transport-- energy requiring
B) facilitated transport
C) drug concentration gradient
Question # 4 (Multiple Choice) Renal excretion factor most likely to be sensitive to drug ionization state:
A) glomerular filtration
B) passive tubular reabsorption
Question # 5 (Multiple Choice) Drug(s) which exhibit(s) a high hepatic" first-pass" effect:
A) lidocaine
B) propranolol
C) both
D) neither
Question # 6 (Multiple Choice) Permanently charged amine form:
A) primary amine
B) secondary amine
C) tertiary amine
D) quaternary amine
Question # 7 (Multiple Answer) For high extraction-ratio drugs, patient to patient bioavailability may vary due to differences in:
A) hepatic function
B) blood flow
C) the presence of hepatic disease
Question # 8 (Multiple Answer) Factors associated with drug absorption that can result in incomplete absorption
A) drug metabolism by gastrointestinal flora
B) drug hydrophilicity (opposite of lipophilicity)
C) drug instability in gastric acid
D) presence of food in the GI tract
E) drug-drug interactions
Question # 9 (Multiple Answer) Drug characteristics contributing to reliable transdermal drug absorption:
A) molecular weight less than 1000
B) drug does not cause histamine release
C) the daily drug requirement is less than 10 mg
D) in saturated aqueous solution, the pH range is 5-9
Question # 10 (Multiple Choice) Concerning parenteral drug administration:
A) less predictable compared to oral administration route
B) not acceptable for unconscious patients
C) rate of drug systemic absorption insensitive to drug solubility in interstitial fluid
D) rate of systemic drug absorption following parenteral administration depends on absorbing capillary membrane surface area
Question # 11 (Multiple Answer) Pharmacokinetic advantages associated with transdermal drug delivery:
A) relatively constant, sustained therapeutic plasma drug concentrations
B) commonly low side-effect incidence
C) good patient compliance
Question # 12 (Multiple Choice) Drugs for which "first-pass" pulmonary uptake may exceed 65% of injected dose:
A) fentanyl
B) alfentanil
C) sufentanil
D) meperidine
E) all of the above
Question # 13 (Multiple Answer) Roots of administration that avoid "first-pass" hepatic effects:
A) sublingual
B) oral
C) transdermal
D) lower rectal suppositories
E) inhalation
Question # 14 (Multiple Choice) Drugs least likely to penetrate across membranes:
A) protein-bound drugs
B) charged drugs
C) neutral drugs
Question # 15 (Multiple Answer) Available for transdermal drug delivery:
A) scopolamine
B) fentanyl
C) nitroglycerin
Question # 16 (Multiple Answer) Concerning "first pass" elimination:
????: Study Temple-All kinds of Study Material MCQs : Pharmacokinetics
A) drug is first transported across the gut wall into the portal circulation
B) drug metabolism may occur in the intestinal wall
C) sometimes extensive drug metabolism may occur in the liver
D) the liver may excrete drug into the bile
E) first-pass effects may reduce drug bioavailability
Question # 17 (Multiple Answer) Factor(s) which effect a drug's volume of distribution:
A) patient's gender
B) patien'ts age
C) presence of disease
D) drug pKa
E) extent of drug-plasma protein binding
Question # 18 (Multiple Choice) Two most important sites for drug elimination:
A) pulmonary and liver
B) liver and gastrointestinal tract
C) kidney and liver
D) skin and liver
E) pulmonary and kidney
Question # 19 (Multiple Choice) Concerning transfer of basic drugs such as nonionized local anesthetics from mother to fetus:
A) fetal pH is higher than maternal pH
B) in fetal distress alkalosis contributes to local anesthetic accumulation
C) concerning maternal blood: fetal blood -- gradient is maintained for continual local anesthetic transfer from maternal circulation to fetal circulation
Question # 20 (Multiple Answer) Characteristics of renal drug excretion:
A) nearly all drugs are filtered at the glomerulus
B) drugs which are weak acids are excreted faster in acidic urinary pH
C) drugs which are weak base is our excreted faster in alkaline urinary pH
D) body fluids where pH differences from blood pH may favor on and trapping include breast milk and aqueous humor (eye)
--------------------------------------------------------------------------
Correct Answers
Now you can see what's hidden
Question # 1 (Multiple Answer) Concerning oral administration -- disadvantages
(B) drug taken orally may cause emesis
(C) drug taken orally may be destroyed by gastric acidity
(D) drug taken orally may be metabolized by gastrointestinal flora
(E) drug taken orally may be in consistently absorbed due to the presence of food
Question # 2 (Multiple Answer) Typical properties of carrier-mediated drug transport:
(B) active transport
(C) energy requiring
(D) inhibitable
Question # 3 (Multiple Choice) Driving force in drug movement in aqueous diffusion model:
Answer: (C) drug concentration gradient
Question # 4 (Multiple Choice) Renal excretion factor I most likely to be sensitive to drug ionization state:
Answer: (B) passive tubular reabsorption
Question # 5 (Multiple Choice) Drug(s) which exhibit(s) a high hepatic" first-pass" effect:
Answer: (C) both
Question # 6 (Multiple Choice) Permanently charged amine form:
Answer: (D) quaternary amine
Question # 7 (Multiple Answer) For high extraction-ratio drugs, patient to patient bioavailability may vary due to differences in:
(A) hepatic function
(B) blood flow
(C) the presence of hepatic disease
Question # 8 (Multiple Answer) Factors associated with drug absorption that can result in incomplete absorption
(A) drug metabolism by gastrointestinal flora
(B) drug hydrophilicity (opposite of lipophilicity)
(C) drug instability in gastric acid
(D) presence of food in the GI tract
(E) drug-drug interactions
Question # 9 (Multiple Answer) Drug characteristics contributing to reliable transdermal drug absorption:
(A) molecular weight less than 1000
(B) drug does not cause histamine release
(C) the daily drug requirement is less than 10 mg
(D) in saturated aqueous solution, the pH range is 5-9
Question # 10 (Multiple Choice) Concerning parenteral drug administration:
????: Study Temple-All kinds of Study Material MCQs : Pharmacokinetics
Answer: (D) rate of systemic drug absorption following parenteral administration depends on absorbing capillary membrane surface area
Question # 11 (Multiple Answer) Pharmacokinetic advantages associated with transdermal drug delivery:
(A) relatively constant, sustained therapeutic plasma drug concentrations
(B) commonly low side-effect incidence
(C) good patient compliance
Question # 12 (Multiple Choice) Drugs for which "first-pass" pulmonary uptake may exceed 65% of injected dose:
Answer: (E) all of the above
Question # 13 (Multiple Answer) Roots of administration that avoid "first-pass" hepatic effects:
(A) sublingual
(C) transdermal
(D) lower rectal suppositories
(E) inhalation
Question # 14 (Multiple Choice) Drugs least likely to penetrate across membranes:
Answer: (A) protein-bound drugs
Question # 15 (Multiple Answer) Available for transdermal drug delivery:
(A) scopolamine
(B) fentanyl
(C) nitroglycerin
Question # 16 (Multiple Answer) Concerning "first pass" elimination:
(A) drug is first transported across the gut wall into the portal circulation
(B) drug metabolism may occur in the intestinal wall
(C) sometimes extensive drug metabolism may occur in the liver
(D) the liver may excrete drug into the bile
(E) first-pass effects may reduce drug bioavailability
Question # 17 (Multiple Answer) Factor(s) which effect a drug's volume of distribution:
(A) patient's gender
(B) patien'ts age
(C) presence of disease
(D) drug pKa
(E) extent of drug-plasma protein binding
Question # 18 (Multiple Choice) Two most important sites for drug elimination:
Answer: (C) kidney and liver
Question # 19 (Multiple Choice) Concerning transfer of basic drugs such as nonionized local anesthetics from mother to fetus:
Answer: (C) concerning maternal blood: fetal blood -- gradient is maintained for continual local anesthetic transfer from maternal circulation to fetal circulation
Question # 20 (Multiple Answer) Characteristics of renal drug excretion:
(A) nearly all drugs are filtered at the glomerulus
(D) body fluids where pH differences from blood pH may favor on and trapping include breast milk and aqueous humor (eye)
MCQS: Pharmcokinetics
????: Study Temple-All kinds of Study Material MCQs : Pharmacokinetics
Question # 1 (Multiple Answer) Factors that could change intrinsic hepatic clearance include:
A) hepatic blood flow
B) induction state of hepatic enzymes
C) hepatic disease
Question # 2 (True/False) In rheumatoid arthritis patients, increased alpha1-acidic glycoprotein may be associated with increased lidocaine protein binding.
A) true
B) false
Question # 3 (Multiple Choice) Hepatic flow-dependent drug elimination refers to:
A) changes in plasma protein concentration
B) rate-limiting step is drug delivery to hepatic elimination sites
????: Study Temple-All kinds of Study Material MCQs : Pharmacokinetics
C) number of functional hepatocytes
D) carrier saturation
E) drug transfer rates across hepatic cell membrane
Question # 4 (Multiple Answer) Characteristic(s) of a drug whose action is terminate by redistribution include:
A) generally long-acting
B) usually a hydrophilic (not very lipid-soluble) drug
C) eventually concentrates usually in adipose (fat) tissue
D) tends to partition slowly into organs such as the brain, even though the brain receives a significant fraction of the cardiac output
Question # 5 (Multiple Choice) Cytochrome P450 induction (increased, amount of P450 enzyme protein) is often associated with:
A) increased enzyme synthesis rates
B) reduced enzyme degradation rates
C) both
D) neither
Question # 6 (Multiple Choice) Microsomal drug metabolizing enzymes are typically associated with:
A) rough endoplasmic reticulum
B) smooth endoplasmic reticulum
Question # 7 (Multiple Answer) Characteristics of drug-protein binding:
A) often parallels drug lipid solubility
B) drug-plasma albumin binding tends to be relatively nonselective
C) real failure he is associated with the reduction in drug-down fraction because of a reduction in plasma albumin concentration
D) in rheumatoid arthritis patients, increased alpha1-acidic glycoprotein tends to promote increased lidocaine protein binding
E) Surgery may result in increases in alpha1-acidic glycoprotein plasma concentration
Question # 8 (Multiple Choice) Examples of "high-extraction" drugs -- related to hepatic drug clearance:
A) morphine
B) meperidine
C) verapamil
D) diltiazem
E) all the above
Question # 9 (Multiple Choice) Pharmacogenetic effects:
A) prolonged mivacurium-induced neuromuscular blockade due to atypical cholinesterase
B) succinylcholine or volatile anesthetic-induced malignant hyperthermia
C) both
D) neither
Question # 10 (Multiple Answer) Characteristics of drug conjugates (following conjugation reactions)
A) more polar
B) more readily excreted
C) typically more pharmacologically active
Question # 11 (Multiple Choice) Termination of pharmacological action of thiopental occurs mainly by:
A) metabolism
B) excretion
C) redistribution
Question # 12 (Multiple Answer) Concerning influence of age on drug responses:variation in response usually due to:
A) reduced cardiac output
B) reduced hepatic perfusion
C) decreased body fat
D) increased protein binding
E) decreased renal function
Question # 13 (Multiple Choice) Reaction type associated with inactivation of succinylcholine, atracurium, and mivacurium.
A) conjugation
B) hydrolysis
C) oxidation
D) reduction
Question # 14 (Multiple Answer) Phase II and reactions:
A) conjugation
B) hydrolysis
C) oxidation
D) reduction
Question # 15 (Multiple Choice) Factors affecting renal clearance of drugs:
A) the presence of renal disease
B) drug secretion rates
C) number of functional nephrons
D) blood flow
E) all of the above
Question # 16 (Multiple Choice) Concerning drug-plasma protein binding:
A) Drugs are seldom bound to plasma proteins
B) volume of distribution is not influenced by protein binding
C) diazepam is an example of the drug that is minimally protein-bound
D) drug clearance is influenced by the extent of protein binding
Question # 17 (Multiple Choice) Mixed function oxidases system is referred to as mediating:
A) phase I system
B) phase II system
Question # 18 (Multiple Answer) Characteristics of drug-protein binding
A) generally theextent of drug-protein binding parallels drug lipids liability
B) drug-plasma albumin binding is usually highly selective
C) renal failure may decrease drug bound fraction because of reduced plasma albumin
D) sulfonamides may displace unconjugated bilirubin from albumin-binding sites (because neonatal bilirubin encephalopathy)
Question # 19 (Multiple Answer) Factors affecting hepatic drug clearance:
A) drug delivery to liver elimination sites
B) extent of plasma protein-bound drug
C) blood flow
D) carrier saturation
E) Wally and filtered in the glomerulus
Question # 20 (Multiple Choice) Factors affecting renal drug secretion rates:
A) carrier saturation
B) drug transfer rates across tubular membranes
C) degree of drug-plasma protein binding
D) rate of drug delivery to secretory sites
E) all the above
Question # 21 (Multiple Choice) Concerning drug-plasma protein binding:
A) A relatively small percentage of drugs are bound to some extent to plasma proteins
B) drug-plasma albumin binding is often highly selective
C) an example of a plasma protein important for drug binding is alpha1-acidic glycoprotein
D) volume of distribution is generally unrelated to protein binding
E) diazepam is an example of a drug that exhibits little plasma protein binding
--------------------------------------------------------------------------
Correct Answers
Now you can see what's hidden
Question # 1 (Multiple Answer) Factors that could change intrinsic hepatic clearance include:
(A) hepatic blood flow
(B) induction state of hepatic enzymes
(C) hepatic disease
Question # 2 (True/False) In rheumatoid arthritis patients, increased alpha1-acidic glycoprotein may be associated with increased lidocaine protein binding.
Answer: True
Question # 3 (Multiple Choice) Hepatic flow-dependent drug elimination refers to:
Answer: (B) rate-limiting step is drug delivery to hepatic elimination sites
Question # 4 (Multiple Answer) Characteristic(s) of a drug whose action is terminate by redistribution include:
(C) eventually concentrates usually in adipose (fat) tissue
Question # 5 (Multiple Choice) Cytochrome P450 induction (increased, amount of P450 enzyme protein) is often associated with:
Answer: (C) both
Question # 6 (Multiple Choice) Microsomal drug metabolizing enzymes are typically associated with:
Answer: (B) smooth endoplasmic reticulum
Question # 7 (Multiple Answer) Characteristics of drug-protein binding:
(A) often parallels drug lipid solubility
(B) drug-plasma albumin binding tends to be relatively nonselective
(D) in rheumatoid arthritis patients, increased alpha1-acidic glycoprotein tends to promote increased lidocaine protein binding
Question # 8 (Multiple Choice) Examples of "high-extraction" drugs -- related to hepatic drug clearance:
Answer: (E) all the above
Question # 9 (Multiple Choice) Pharmacogenetic effects:
Answer: (C) both
Question # 10 (Multiple Answer) Characteristics of drug conjugates (following conjugation reactions)
(A) more polar
(B) more readily excreted
Question # 11 (Multiple Choice) Termination of pharmacological action of thiopental occurs mainly by:
Answer: (C) redistribution
Question # 12 (Multiple Answer) Concerning influence of age on drug responses:variation in response usually due to:
(A) reduced cardiac output
(B) reduced hepatic perfusion
(E) decreased renal function
Question # 13 (Multiple Choice) Reaction type associated with inactivation of succinylcholine, atracurium, and mivacurium.
Answer: (B) hydrolysis
Question # 14 (Multiple Answer) Phase II and reactions:
(A) conjugation
(B) hydrolysis
(C) oxidation
(D) reduction
Question # 15 (Multiple Choice) Factors affecting renal clearance of drugs:
Answer: (E) all of the above
Question # 16 (Multiple Choice) Concerning drug-plasma protein binding:
Answer: (D) drug clearance is influenced by the extent of protein binding
Question # 17 (Multiple Choice) Mixed function oxidases system is referred to as mediating:
Answer: (A) phase I system
Question # 18 (Multiple Answer) Characteristics of drug-protein binding
(A) generally theextent of drug-protein binding parallels drug lipids liability
(D) sulfonamides may displace unconjugated bilirubin from albumin-binding sites (because neonatal bilirubin encephalopathy)
Question # 19 (Multiple Answer) Factors affecting hepatic drug clearance:
(A) drug delivery to liver elimination sites
(B) extent of plasma protein-bound drug
(C) blood flow
Question # 20 (Multiple Choice) Factors affecting renal drug secretion rates:
Answer: (E) all the above
Question # 21 (Multiple Choice) Concerning drug-plasma protein binding:
Answer: (C) an example of a plasma protein important for drug binding is alpha1-acidic glycoprotein
